Skinvisible SKVI
OTC SKVI
$0.20 +0.00 (+0.00%)
At close: Sep 28, 2026 · 4:00 PM EDT

Skinvisible (SKVI) EV to EBITDA (2021 - 2022)

Updated

Skinvisible's EV to EBITDA was 14.16 in Q3 2022, up 118.7% from 6.47 a year earlier and up 506.8% from the prior quarter.

Analysis

Skinvisible (SKVI) EV to EBITDA (2021 - 2022) Analysis & Trends

On a trailing twelve-month basis, Skinvisible's EV to EBITDA was 8.63 through Sep 30, 2022, up 73.2% year-over-year; for FY2021, it came in at 4.97.

  • Per Business Quant data, SKVI's EV to EBITDA in the three quarters before Q3 2022 was 2.33 (Q2 2022), 2.37 (Q1 2022) and 4.97 (Q4 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Skinvisible 1.08 Mn 1.07 Mn 5,000.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 14.16
Jun 30, 2022 2.33
Mar 31, 2022 2.37
Dec 31, 2021 4.97
Sep 30, 2021 6.47
API Access

Skinvisible EV to EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-ebitda&ticker=SKVI&period=max&api_key=YOUR_API_KEY